Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

UroGen Pharma (URGN) Raw Materials: 2020

Historic Raw Materials for UroGen Pharma (URGN) over the last 1 years, with Dec 2020 value amounting to $1.1 million.

  • UroGen Pharma's Raw Materials was N/A to $2.4 million in Q1 2021 from the same period last year, while for Mar 2021 it was $2.4 million, marking a year-over-year change of. This contributed to the annual value of $1.1 million for FY2020, which is N/A change from last year.
  • UroGen Pharma's Raw Materials amounted to $1.1 million in FY2020.
  • UroGen Pharma's 5-year Raw Materials high stood at $1.1 million for FY2020, and its period low was $1.1 million during FY2020.
  • In the last 1 years, UroGen Pharma's Raw Materials had a median value of $1.1 million in 2020 and averaged $1.1 million.